Prolific retinopathy in a diabetic patient Image: Mike Jackson
As a Life Science Company, Bayer believes that regular eye screening is essential for the prevention of vision loss, especially for those at risk of retinal diseases, including macular degeneration, diabetic macular oedema and diabetic retinopathy.
The global rise of diabetes and the associated eye conditions that affect those with the condition have highlighted the essential role of optometry in the prevention of vision loss and blindness.
Optometrists work on the front line of detection. They play a crucial role in identification of disease and eye care, and design necessary referral pathways for those needing further treatment and support.
As a company committed to science and innovation, Bayer values the opportunity to assist optometrists in early eye disease detection and therefore improving patients’ quality of life.